v3 Template
M

Marinomed Biotech AG

Biotechnology
Founded
--
Employees
--
Total Funding
$2.5M
Funding Rounds
1
Last Funding
2025-09-01

About Marinomed Biotech AG

Marinomed Biotech AG is a biotechnology company with a vision to transform the lives of people suffering from diseases with limited or no treatment options, focusing on virology and immunology. Driven by curiosity and patented technologies, they aim to develop innovative therapies and unique solutions through a deep understanding of science.

Products & Services

Budesolv:A product in Marinomed's portfolio focused on therapeutic applications.
Solv4U Technology Partnerships & Services:A platform for technology partnerships and services to support drug development.

Specialties

Virology Immunology Viral Infectious Diseases Autoreactive Immune Disorders Innovative Therapies

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Convertible Bond
T: -
FT: Convertible Bond
A: 2500000
MR: -
FA: 2.5 million EUR
FAN: 2500000
D: 2025-09-01
FD: 2025-09-01
1 investors
Convertible Bond Latest
2025-09-01
$2.5M
1 investor (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

No team data available

Team information is not yet available for this company

Recent News

Marinomed Biotech AG Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro